Inventory

12 Months Ended

Dec. 31, 2022

Inventory Disclosure [Abstract]

Inventory

Inventory

Inventory consisted of the following (in thousands):

	December 31,
	2022		2021
Raw materials	$	—	$	—
Work-in-process	2,994		—
Finished goods	26		—
Total inventory	$	3,020	$	—

All of the Company’s inventory relates to the manufacturing of KRAZATI subsequent to FDA approval in December 2022. There were no inventory write downs during the year ended December 31, 2022.